期刊文献+

Ⅱ型神经纤维瘤基因突变型的构建及生物学功能研究 被引量:3

Construction and characterization of mutants in the neurofibromatosis type 2 tumor suppressor gene
原文传递
导出
摘要 目的构建Ⅱ型神经纤维瘤(NF2)抑癌基因546位点突变的真核表达载体,并在大鼠神经鞘瘤细胞(RT4)中诱导表达。方法用定点突变法将pEGFP—Nl—NF2第546位异亮氨酸(Ile)突变为蛋氨酸(Met)从而构建NF2突变子pEGFP—NI—NF2^△Ile546Met,经酶切和测序鉴定后用脂质体法将其转染至RT4细胞,同时设pEGFP—N1-NF2转染组做为对照,Western blot法检测细胞pEGFP—NF2蛋白的表达,MTT法检测转染后细胞的增殖情况。结果酶切测序证实定点突变成功,Westem blot结果显示RT4细胞能表达pEGFP—NF2蛋白,pEGFP-Nl-NF2△Ile546Met转染组RT4细胞抑制率低于pEGFP—N1-NF2转染组,差异有统计学意义(P〈0.05)。结论成功构建了1个能够在RT4细胞中表达的单个点突变的NF2基因真核表达载体。 Objective To construct the eukaryotic expression vector of mutants in the neurofibromatosis type 2 (NF2) tumor suppressor gene and observe its expression in rat schwannoma cell line RT4. Methods Site-directed mutagenesis was performed to induce the mutation of the codons for the residue Ile 546 in pEGFP-N 1-NF2 into Met to construct the muton of pEGFP-N 1-NF2△Ile546Met. After lipofectin-mediated transient transformation of RT4 with the plasmids containing the mutation and the one without mutation, respectively, the mRNA and protein expression levels of NF2 were determined using fluorescence imaging and Western blotting. The cell proliferation was determined by the MTT assay. Results DNA sequence analysis confirmed the success of site-directed mutagenesis and Western blotting showed that pEGFP-NF2 protein could be expressed in the RT4 cells. The RT4 cell inhibition rate in the pEGFP-N1-NF2△Ile546Met transfection group was statistically lower than that in the pEGFP-N1-NF2 transfected group (P〈0.05). Conclusion The recombinant plasmids pEGFP-N1-NF2△Ile546Met has been successfully constructed with efficient expressions in RT4.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第12期1189-1192,共4页 Chinese Journal of Neuromedicine
基金 上海市科委启明星跟踪计划(04qmhl414) 上海市科委自然基金(06ZR14064)
关键词 定点突变 真核表达载体 Ⅱ型神经纤维瘤 抑癌基因 神经鞘瘤细胞 Site-directed mutagenesis Eukaryotic expression vector Neurofibromatosis type 2 Tumor suppressor gene Rat schwannoma cell
  • 相关文献

参考文献15

  • 1Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment[J]. Neurosurg Focus, 2007, 23(5): E4.
  • 2Schefler AC, Dubovy SR, Berrocal AM. Optical coherence tomography characteristics of epiretinal membranes in neurofibromatosis 2[J]. Ophthalmic Surg Lasers Imaging, 2008, 39 (1): 73-77.
  • 3Sestini R, Bacci C, Metvenzano A, et al. mechanism involving SMARCB 1 Evidence of a four-hit schwannomatosis-associated schwannomas [J] 29(2): 227-231. and NF2 in Hum Mutat, 2008,.
  • 4Jacoby LB, Jones D, Davis K, et al. Molecular analleis of the NF2 tumor-suppressor gene in schwannomatosis [J]. Am J Hum Genet, 1997, 61(6): 1293-1230.
  • 5Fisher LM, Doherty JK, Lev MH, et al. Distribution ofnonvestibular cranial nerve schwannomas in neurofibromatosis 2 [J]. Otol Nettrotol, 2007, 28(8): 1083-1090.
  • 6Evans DG, Ramsden RT, Shenton A, et al. What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?[J]. J Neurosurg, 2008, 108(1): 92-96.
  • 7卞留贯,孙青芳,沈建康,赵卫国,罗其中,张天锡.神经鞘瘤的NF_2基因2、4、6、13外显子突变分析[J].中国神经精神疾病杂志,2001,27(6):401-404. 被引量:9
  • 8Bian LG, Tirakotai W, Sun QF, et al. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China[J]. J Neurooncol, 2005, 73(3): 253-260.
  • 9沈建康,卞留贯,孙青芳,赵卫国,罗其中,王利民.神经鞘瘤的NF2基因突变分析[J].中华神经外科杂志,2002,18(2):96-99. 被引量:12
  • 10贺子建,王晓强,卞留贯,孙青芳.NF2基因及其蛋白merlin的生物学研究进展[J].国际神经病学神经外科学杂志,2006,33(2):194-197. 被引量:4

二级参考文献19

  • 1BIAN Liu-guan,SUN Qing-fang,Tirakotai Wuttipong,ZHAO Wei-guo,SHEN Jian-kang,LUO Qi-zhong,Bertalanffy Helmut.Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells[J].Chinese Medical Journal,2005(18):1517-1524. 被引量:8
  • 2Muranen T, Gronholm M, Renkema GH, et al. Cell cycle-dependent nucleocytoplasmie shuttling of the neurofibromatosis 2 turnout suppressor merlin. Oncogene, 2005 , 24 ( 7 ) : 1150-1158.
  • 3Lee JY, Kim H, Ryu CH, et al. Merlin , a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biolchem, 2004,279 ( 29 ) :30265- 30273.
  • 4Rong R, Suraee EI, Haipek CA, et al, Serine 518 phosphorylation modulates merlin intramoleeular association and binding to critical effeetors important for NF2 growth suppression, Oneogene, 2004,23(52) :8447-8454.
  • 5Alflhan K, Heiska L, Gronholm M, et al. Cyclic AMP-dependent protein kinase phosphorylates merlin at sefine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization. J Biol Chem, 2004, 279 ( 18 ): 18559-18566.
  • 6Rangwala R, Banine F, Borg JP, et al. Erbin regulates mitogen-activated protein ( MAP ) kinase activation and MAP kinase-dependent interactions between merlin and adherens junction protein complexes in schwann cells. J Biol Chem, 2005,280(12) :11790-11797.
  • 7Kim H, Kwak NJ , Lee JY, et al. Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53. J Biol Chem, 2004, 279(9):7812-7818.
  • 8Rong R, Tang XL, David H, et al. Neurofibromatosis 2 ( NF2 )tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L PNAS ,2004,101( 52 ) :18200-18205.
  • 9Gonzalez-Gomez P, Bello MJ, Alonso ME, et al. CpG Island methylation in sporadic and neurofibroma-tis type 2-associated schwannomas. Clin Cancer Res, 2003, 9 ( 15 ) : 5601-5606.
  • 10Hirokawa Y, Tikoo A, Huynh J, et al. A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAKI inhibitor.Cancer J,2004,10 ( 1 ) :20-26.

共引文献17

同被引文献20

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部